Get started
Author

Steven C. Cheng

Observed names: S.C. Cheng, Steven CHENG, Steven Cheng
ORCID: 0000-0001-6929-9440
Observed ORCID: 0000-0001-6929-9440
OpenAlex ID: A5033331971
A Randomized, Double-Blind, Placebo-Controlled Trial of Niacinamide for Reduction of Phosphorus in Hemodialysis Patients
2008 · Steven C. Cheng, Daniel O. Young, et al. · Clinical Journal of the American Society of Nephrology · 124
Gadolinium-Containing Magnetic Resonance Imaging Contrast and Nephrogenic Systemic Fibrosis: A Case-Control Study
2008 · Alexander J. Kallen, Michael A. Jhung, et al. · American Journal of Kidney Diseases · 93
Effects of Phosphate Binder Therapy on Vascular Stiffness in Early-Stage Chronic Kidney Disease
2013 · Michael E. Seifert, Lisa de las Fuentes, et al. · American Journal of Nephrology · 75
The Effect of Oral Niacinamide on Plasma Phosphorus Levels in Peritoneal Dialysis Patients
2009 · Daniel O. Young, Steven C. Cheng, et al. · Peritoneal Dialysis International · 44
Left Ventricular Mass Progression despite Stable Blood Pressure and Kidney Function in Stage 3 Chronic Kidney Disease
2014 · Michael E. Seifert, Lisa de las Fuentes, et al. · American Journal of Nephrology · 38
PDF
Vitamin D and outcomes in chronic kidney disease
2007 · Steven Cheng, Daniel Coyne · Current Opinion in Nephrology & Hypertension · 29
A Novel Approach to Assessing Professionalism in Preclinical Medical Students Using Multisource Feedback Through Paired Self- and Peer Evaluations
2017 · Amanda R. Emke, Steven Cheng, et al. · Teaching and Learning in Medicine · 20
Once-weekly intravenous paricalcitol in the treatment of secondary hyperparathyroidism in hemodialysis patients
2005 · M.E. Staniforth, S.C. Cheng, et al. · Clinical Nephrology · 13
Developing Professionalism via Multisource Feedbackin Team-Based Learning
2015 · Amanda R. Emke, Steven Cheng, et al. · Teaching and Learning in Medicine · 11
Paricalcitol capsules for the control of secondary hyperparathyroidism in chronic kidney disease
2006 · Steven Cheng, Daniel Coyne · Expert Opinion on Pharmacotherapy · 10
Oral paricalcitol for the treatment of secondary hyperparathyroidism in chronic kidney disease
2006 · Steven Cheng · Therapeutics and Clinical Risk Management · 10
PDF
Nephrogenic systemic fibrosis: A nephrologist's perspective
2007 · Georges SAAB, Steven CHENG · Hemodialysis International · 7
“Make Me a Match”
2022 · Steven C. Cheng, Kurtis A. Pivert, et al. · Clinical Journal of the American Society of Nephrology · 3
Acute kidney injury on chronic kidney disease: from congestive heart failure to light chain deposition disease and cast nephropathy in multiple myeloma
2019 · Sana Shaikh, Christian Nwankwo, et al. · Journal of Community Hospital Internal Medicine Perspectives · 2
PDF
112
2007 · Alexander Kallen, Michael Jhung, et al. · American Journal of Kidney Diseases · 1
Secondary Hyperparathyroidism in the Diabetic Patient with Chronic Kidney Disease
2005 · Steven Cheng, Daniel Coyne · US Endocrinology · 1
Front & Back Matter
2013 · David T. Gilbertson, Yelena Slinin, et al. · American Journal of Nephrology
Paricalcitol in the treatment of secondary hyperparathyroidism
2006 · Steven Cheng, Daniel Coyne · Expert Review of Endocrinology & Metabolism
Works count: 20
Citation count: 481
H-index: 10
I10-index: 11
Year
Topic
Type